Gen Book 2018
Genomma Lab Internacional S.A.B. de C.V one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence, develops, sells and markets a broad range of Premium brandend products, many of which are leaders in their categories.
Mr. Jorge Brake, Chief Executive Officer, commented: “2019 was characterized by challenges, great achievements and exciting new opportunities for Genomma Lab. We began the year implementing Genomma’s redesigned strategic plan, led by its four key pillars, which has meaningfully improved and strengthened our business model and enabled us to achieve improved results reflecting the renewed commitment throughout our organization." He added: "We expect 2020 to again present challenges, as well as new prospects to broaden our reach and fuel future growth. We will further leverage our strong and advantaged portfolio, best in class innovation, and the excellent go-to-market and supply capabilities for which Genomma is known. We’ll also maintain our relentless focus on growth, operational performance and people to further build value for our stakeholders, partners, employees and investors.”
Chief Executive Officer
February 26, 2020
To improve and preserve the health and well-being of our customers through innovative, safe and effective products, providing development opportunities to our collaborators, profitability to our shareholders and positively impacting our community and environment.
To be the leading company in the pharmaceutical and personal care products markets in which we are active; and to be recognized for our positive impact on the health and welfare of people, communities and the environment.
of net sales
of net sales
of net sales
Points of sale+290,000
Sales 2018 (MXN mm)$11,921
(OTC: 49%2, PC: 51%3)
EBITDA (MXN mm)2,336
1As a percentage of 2018 consolidated sales, 2Over The Counter, 3Personal Care
Genomma Lab is committed to enriching the well-being of our society by improving life quality of the consumers of our products via the investigation and analysis of the optimal ingredients for the development and commercialization of our personal care and OTC pharmaceutical products, and in so doing, generating the maximum levels of profitability possible for our investors.
Rodrigo Herrera Aspra
Founder and Chairman of the Board
Genomma Lab, a Mexican company that has changed the business model in the pharmaceutical industry, presents events, news and financial statements in our website for investors.
Corporate Social Responsibility
Our People. Responsible Actions
The generation of value is the result of the commitment, talent and integrity of our team.
Our Communities. Responsible Actions
We redouble efforts in social welfare programs, both internally and externally.
The quality of our products is what most interests us and the satisfaction of our customers is what pleases us the most.